Skip to main content

Table 1 Basic demographics of stroke patients and controls

From: Association between plasma levels of hyaluronic acid and functional outcome in acute stroke patients

  Controls (n = 159) Stroke patients (n = 207) Stroke subtypes
    ICH (n = 43) IS (n = 163)
Age (years) 62.7 ± 7.5 64.3 ± 13.8 60.1 ± 14.7 65.4 ± 13.5*
Male 90 (56.6) 139 (67.1) 28 (65.1) 111 (68.1)
Body mass index (kg/m2) 25.7 ± 4.1 25.4 ± 3.8 24.0 ± 3.7 25.7 ± 3.8
Diabetes mellitus 77 (48.4) 77 (37.2) 10 (23.3) 67 (41.1)*
Hypertension 95 (59.7) 158 (76.3) 39 (90.7) 119 (73.0)*
Hyperlipidemia 40 (25.2) 62 (30.0) 9 (20.9) 53 (32.5)
Medication for:
Diabetes mellitus NA 58 (28.0) 5 (11.6) 53 (32.5)*
Hypertension NA 113 (54.6) 22 (51.1) 91 (55.8)
Hyperlipidemia NA 28 (13.5) 3 (7.0) 25 (15.3)
HA <48 hours (ng/ml)    252.6 ± 188.3 211.0 ± 206.9
HA 48 to 72 hours (ng/ml)    554.0 ± 1127.7 287.1 ± 540.7*
  1. Values are shown as number (percentage) or mean ± standard deviation. HA, hyaluronic acid; ICH, intracerebral hemorrhage; IS, ischemic stroke; NA, not available. *P < 0.05 versus ICH.